Free Trial

Teva Pharmaceutical Industries (TEVA) Earnings Date, Estimates & Call Transcripts

Teva Pharmaceutical Industries logo
$18.45
+0.01 (+0.05%)
(As of 11/1/2024 ET)

Teva Pharmaceutical Industries Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 6Before Market OpensConfirmed
Actual EPS
(Jul. 31)
$0.58 Beat By $0.03
Consensus EPS
(Jul. 31)
$0.55

Teva Pharmaceutical Industries posted Q2 2024 earnings on July 31, 2024, reporting an EPS of $0.58, which beat analysts' consensus estimates of $0.55 by $0.03. Quarterly revenue was reported to be $4.16 billion, above analyst estimates of $3.99 billion. With a trailing EPS of -$0.39, Teva Pharmaceutical Industries' earnings are expected to grow 14.16% next year, from $2.33 to $2.66 per share.

TEVA Upcoming Earnings

Teva Pharmaceutical Industries' next earnings date is scheduled for Wednesday, November 6, 2024, with a conference call scheduled for at 8:00 AM ET. Interested parties can register for or listen to the call.

Get Teva Pharmaceutical Industries Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Teva Pharmaceutical Industries and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TEVA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TEVA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Teva Pharmaceutical Industries Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.48$0.48$0.48 
Q2 20241$0.56$0.56$0.56 
Q3 20241$0.57$0.57$0.57 
Q4 20241$0.67$0.67$0.67 
FY 20244$2.28$2.28$2.28 
Q1 20251$0.44$0.44$0.44 
Q2 20251$0.58$0.58$0.58 
Q3 20251$0.66$0.66$0.66 
Q4 20251$0.83$0.83$0.83 
FY 20254$2.51$2.51$2.51 
Q1 20261$0.50$0.50$0.50 
Q2 20261$0.64$0.64$0.64 

Teva Pharmaceutical Industries Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/6/2024
(Confirmed)
-------  
7/31/2024Q2 2024$0.55$0.58+$0.03$1.91$3.99B$4.16B
5/8/2024Q1 2024$0.49$0.46 -$0.03$1.04$3.70B$3.82B    
1/31/2024Q4 2023$0.73$0.98+$0.25$1.55$3.97B$4.46B    
11/8/2023Q3 2023$0.57$0.60+$0.03$1.09$3.73B$3.90B        
8/2/2023Q2 2023$0.52$0.54+$0.02$1.85$3.69B$3.88B    
5/10/2023Q1 2023$0.55$0.37 -$0.18$0.92$3.60B$3.66B    
2/8/2023Q4 2022$0.64$0.68+$0.04$2.46$3.90B$3.88B    
11/3/2022Q3 2022$0.58$0.56 -$0.02$1.07$3.86B$3.60B        

Teva Pharmaceutical Industries Earnings - Frequently Asked Questions

Teva Pharmaceutical Industries has confirmed that its next quarterly earnings data will be published on Wednesday, November 6th, 2024. Learn more on TEVA's earnings history.

In the previous quarter, Teva Pharmaceutical Industries (NYSE:TEVA) reported $0.58 earnings per share (EPS) to beat the analysts' consensus estimate of $0.55 by $0.03. Learn more on analysts' earnings estimate vs. TEVA's actual earnings.

Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded annual revenue of $15.85 billion.

Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded net income of -$559 million. TEVA has generated -$0.39 earnings per share over the last four quarters.

Teva Pharmaceutical Industries (NYSE:TEVA) has a forward price-to-earnings ratio of 7.92. The price/earnings-to-growth ratio is 1.33.

Teva Pharmaceutical Industries's earnings are expected to grow from $2.33 per share to $2.66 per share in the next year, which is a 14.16% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:TEVA) was last updated on 11/3/2024 by MarketBeat.com Staff
From Our Partners